CGP-42112
CAS No. 127060-75-7
CGP-42112( CGP42112 | CGP 42112 | CGP-42112A )
Catalog No. M11134 CAS No. 127060-75-7
CGP-42112 (CGP42112A) is a highly potent, selective Angiotensin-II subtype 2 receptor(AT2 receptor) agonist with Ki of 0.24 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1017 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCGP-42112
-
NoteResearch use only, not for human use.
-
Brief DescriptionCGP-42112 (CGP42112A) is a highly potent, selective Angiotensin-II subtype 2 receptor(AT2 receptor) agonist with Ki of 0.24 nM.
-
DescriptionCGP-42112 (CGP42112A) is a highly potent, selective Angiotensin-II subtype 2 receptor(AT2 receptor) agonist with Ki of 0.24 nM; significantly inhibits cGMP production from the basal value, also significantly inhibits TH-enzyme activity from the basal value in cultured porcine adrenal medullary cells; antagonizes Ang-II induced contractions in rabbit aortic rings with IC50 of 1.85 uM.
-
In VitroCGP-42112 (≥1 nM) significantly inhibits cGMP production from the basal value. CGP-42112 (≥1 nM) significantly inhibits TH-enzyme activity from the basal value. These inhibitory effects of CGP-42112 on TH-enzyme activity and-cGMP production are abolished by PD123319 (AT(2)-R antagonist) while CV-11974 (AT(1)-R antagonist) is ineffective. CGP-42112 binds selectively to the AT2 angiotensin II receptor subtype. [125I]CGP-42112 binds with higher affinity in the brain than in the adrenal. beta-Mercaptoethanol enhanced [125I]CGP-42112 binding in the brain, but does not alter its binding in the adrenal. CGP-42112 binds with high affinity (Kd = 0.07-0.3 nM, depending on the area studied). CGP-42112 binding is selective for AT2 receptors, as determined by lack of competition with the AT1 ligand losartan, and competition by the AT2 ligands PD 123177 and unlabeled CGP-42112 and the non-selective peptides Ang II and angiotensin III (Ang III).
-
In VivoIntravenous infusions of CGP-42112 (0.1 and 1 mg kg-1 min-1) and PD 123319 (0.36 and 1 mg kg-1 min-1) shifted the upper limit of CBF autoregulation toward higher blood pressures without affecting baseline CBF.
-
SynonymsCGP42112 | CGP 42112 | CGP-42112A
-
PathwayGPCR/G Protein
-
TargetAngiotensin Receptor
-
RecptorAngiotensin Receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number127060-75-7
-
Formula Weight1052.185
-
Molecular FormulaC52H69N13O11
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 350 mg/mL
-
SMILESCC[C@H](C)[C@@H](C(O)=O)NC([C@H]1N(C([C@H](CC2=CNC=N2)NC([C@H](CCCCNC([C@H](CCCNC(N)=N)NC(OCC3=CC=CC=C3)=O)=O)NC([C@H](CC4=CC=C(O)C=C4)NC(C5=CC=CN=C5)=O)=O)=O)=O)CCC1)=O
-
Chemical NameL-Isoleucine, N-(3-pyridinylcarbonyl)-L-tyrosyl-N6-[N2-[(phenylmethoxy)carbonyl]-L-arginyl]-L-lysyl-L-histidyl-L-prolyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hakam AC, et al. Am J Physiol Renal Physiol. 2006 Jun;290(6):F1430-6.
2. Takekoshi K, et al. Biochem Biophys Res Commun. 2000 Jun 7;272(2):544-50.
3. N?veri L, et al. J Cereb Blood Flow Metab. 1994 Jan;14(1):38-44.
4. N?veri L, et al. Acta Physiol Scand Suppl. 1995;630:1-48.
molnova catalog
related products
-
TD-0212
TD-0212 (TD0212) is a potent, orally efficacious, dual AT1 antagonist/Neprilysin (NEP) inhibitor with pKi of 8.9 (AT1) and pIC50 of 9.2 (NEP).
-
Azilsartan medoxomil...
An orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM.
-
Sparsentan
Sparsentan (RE-021) is a highly potent dual angiotensin II and endothelin A receptor antagonist with Kis of 0.8 and 9.3 nM, respectively.
Cart
sales@molnova.com